167 related articles for article (PubMed ID: 1348434)
1. Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment.
Wagner JE; Broxmeyer HE; Byrd RL; Zehnbauer B; Schmeckpeper B; Shah N; Griffin C; Emanuel PD; Zuckerman KS; Cooper S
Blood; 1992 Apr; 79(7):1874-81. PubMed ID: 1348434
[TBL] [Abstract][Full Text] [Related]
2. Juvenile chronic myelogenous leukemia: in vitro characterization before and after allogeneic bone marrow transplantation.
Zecca M; Rosti V; Pinto L; Comoli P; Carrà AM; Prete L; Bonetti F; Pedrazzoli P; Locatelli F; Cazzola M
Med Pediatr Oncol; 1995 Mar; 24(3):166-70. PubMed ID: 7838038
[TBL] [Abstract][Full Text] [Related]
3. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia.
Emanuel PD; Bates LJ; Zhu SW; Castleberry RP; Gualtieri RJ; Zuckerman KS
Exp Hematol; 1991 Nov; 19(10):1017-24. PubMed ID: 1915702
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
Hassan HT; Krog C; Stockschläder M; Schleimer B; Zeller W; Krüger W; Erttmann R; Zander AR
Anticancer Res; 1997; 17(1B):589-99. PubMed ID: 9066585
[TBL] [Abstract][Full Text] [Related]
5. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults.
Broxmeyer HE; Hangoc G; Cooper S; Ribeiro RC; Graves V; Yoder M; Wagner J; Vadhan-Raj S; Benninger L; Rubinstein P
Proc Natl Acad Sci U S A; 1992 May; 89(9):4109-13. PubMed ID: 1373894
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
[TBL] [Abstract][Full Text] [Related]
7. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
[TBL] [Abstract][Full Text] [Related]
8. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
9. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture.
Sawai N; Koike K; Ito S; Okumura N; Kamijo T; Shiohara M; Amano Y; Tsuji K; Nakahata T; Oda M
Exp Hematol; 1996 Feb; 24(2):116-22. PubMed ID: 8641332
[TBL] [Abstract][Full Text] [Related]
10. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.
Laughlin MJ; Kirkpatrick G; Sabiston N; Peters W; Kurtzberg J
Ann Hematol; 1993 Dec; 67(6):267-76. PubMed ID: 7506580
[TBL] [Abstract][Full Text] [Related]
12. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for relapsed non-Hodgkin's lymphoma: blood and bone marrow progenitor growth studies. A phase II Eastern Cooperative Oncology Group Trial.
Lazarus HM; Andersen J; Chen MG; Variakojis D; Mansour EG; Oette D; Arce CA; Oken MM; Gerson SL
Blood; 1991 Aug; 78(3):830-7. PubMed ID: 1859894
[TBL] [Abstract][Full Text] [Related]
13. Central role of tumour necrosis factor, GM-CSF, and interleukin 1 in the pathogenesis of juvenile chronic myelogenous leukaemia.
Freedman MH; Cohen A; Grunberger T; Bunin N; Luddy RE; Saunders EF; Shahidi N; Lau A; Estrov Z
Br J Haematol; 1992 Jan; 80(1):40-8. PubMed ID: 1311195
[TBL] [Abstract][Full Text] [Related]
14. HLA-haploidentical umbilical cord blood stem cell transplantation in a child with advanced leukemia: clinical outcome and analysis of hematopoietic recovery.
Miniero R; Busca A; Roncarolo MG; Saitta M; Iavarone A; Timeus F; Biondi A; Amoroso A; Perugini L; Ciuti E
Bone Marrow Transplant; 1995 Aug; 16(2):229-40. PubMed ID: 7581141
[TBL] [Abstract][Full Text] [Related]
15. Comparison of outcome of allogeneic bone marrow transplantation with and without granulocyte colony-stimulating factor (lenograstim) donor-marrow priming in patients with chronic myelogenous leukemia.
Ji SQ; Chen HR; Wang HX; Yan HM; Pan SP; Xun CQ
Biol Blood Marrow Transplant; 2002; 8(5):261-7. PubMed ID: 12064363
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells.
Traycoff CM; Abboud MR; Laver J; Brandt JE; Hoffman R; Law P; Ishizawa L; Srour EF
Exp Hematol; 1994 Feb; 22(2):215-22. PubMed ID: 7507862
[TBL] [Abstract][Full Text] [Related]
17. Use of granulocyte-macrophage colony-stimulating factor in two children treated with cord blood transplantation.
Vowels MR; Tiedemann K; Lam-Po-Tang R; Tucker DP
Blood Cells; 1994; 20(2-3):249-54; discussion 254-5. PubMed ID: 7749102
[TBL] [Abstract][Full Text] [Related]
18. GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation.
Brandwein JM; Nayar R; Baker MA; Sutton DM; Scott JG; Sutcliffe SB; Keating A
Exp Hematol; 1991 Mar; 19(3):191-5. PubMed ID: 1995310
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte-macrophage colony-stimulating factor is an endogenous regulator of cell proliferation in juvenile chronic myelogenous leukemia.
Gualtieri RJ; Emanuel PD; Zuckerman KS; Martin G; Clark SC; Shadduck RK; Dracker RA; Akabutu J; Nitschke R; Hetherington ML
Blood; 1989 Nov; 74(7):2360-7. PubMed ID: 2679915
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic bone marrow transplantation for chronic myeloid leukemia using HLA identical sibling donors primed with G-CSF.
Chen HR; Ji SQ; Wang HX; Yan HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Aug; 10(4):340-6. PubMed ID: 12513770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
